Investor List:

Top Pharmaceuticals Series B Investors in LatAm (Latin America) (19)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of José Eduardo Ribeiro Guinle, Partner at DNA Capital
José Eduardo Ribeiro Guinle
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Photo of Carlos Esteban Villa, Partner at Impulsum Ventures
Carlos Esteban Villa
Sweet spot: $500K
Range: $500K - $500K
Investors in Santa Monica (CA), Investors in Medellin (Colombia), Investors in Barcelona (Spain)
Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Consumer Internet (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series A), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in Consumer Internet (Seed), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in FinTech (Series B), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Internet (Series A), Investors in FinTech (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Digital Health (Series A), Investors in FinTech (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Seed)
Photo of Luiz Felipe D Martins Costa, Partner at DNA Capital
Luiz Felipe D Martins Costa
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Photo of Daniel Restrepo Arango, Partner at Impulsum Ventures
Daniel Restrepo Arango
Sweet spot: $500K
Range: $500K - $500K
Investors in Barcelona (Spain), Investors in Medellin (Colombia), Investors in Santa Monica (CA)
Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Semiconductors (Series B), Investors in Pharmaceuticals (Series B), Investors in Semiconductors (Series B), Investors in Pharmaceuticals (Series B), Investors in Semiconductors (Seed), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series A), Investors in FinTech (Series B), Investors in Health IT (Seed), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in Semiconductors (Series B), Investors in Digital Health (Seed), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Seed), Investors in FinTech (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Consumer Internet (Series A), Investors in FinTech (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Internet (Series B), Investors in Digital Health (Series A), Investors in FinTech (Series B), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in Consumer Internet (Series A), Investors in FinTech (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Seed)
Photo of Luiz Noronha, Partner at DNA Capital
Luiz Noronha
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in SaaS (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in FinTech (Series B), Investors in Health IT (Seed), Investors in SaaS (Series A), Investors in SaaS (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in SaaS (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in FinTech (Series B), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in SaaS (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Mitesh Rao, Venture Partner at DNA Capital
Mitesh Rao
DNA Capital·Venture Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Photo of Thayan Hartmann, Partner at DNA Capital
Thayan Hartmann
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Photo of Partha Mishra, Partner at DNA Capital
Partha Mishra
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Get new data & insights delivered to your inbox
Firms investing in this space